*By Christian Smith*
After an overdose earlier this week, Demi Lovato's life was reportedly saved by Narcan, a nasal administrator of naloxone that counteracts the effects of opioids. When administered quicklyーthrough either nasal mist or injectionーnaloxone can temporarily halt an overdose, allowing EMTs enough time to respond. The medication is available without a prescription in 49 states, and the generic version costs about $20 per dose.
But all merits aside, is the drug's accessibility enabling addicts to push their limits?
Dr. Roger Crystal, the lead inventor of Narcan and CEO of Opiant Pharmaceuticals, says there's little evidence to support that concern.
"Addiction like any kind of chronic disease is something you can control using better medication, but ultimately you can't cure," Crystal told Cheddar. "To think about an opioid addict behaving rationally and saying, 'well because I have access to Narcan I'll shoot more heroin, inject more heroin' there's no proof for that whatsoever."
Naloxone is considered some of the best ammunition on the front lines of America's growing opioid epidemic. A reported 2 million Americans have an addition to opioidsーand the number isn't going down. U.S. Surgeon General Jerome Adams [issued an advisory](https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html) in April urging anyoneーand their close family and friendsーwho uses painkillers, heroin, fentanyl, or other opioids to carry naloxone in case of an emergency.
Crystal isn't stopping at Narcan: he told Cheddar he's also developing a heroin vaccine, suggesting the inventor has lofty ambitions for the future of overdose prevention.
Although Crystal may be aware of lingering ethical concerns, he doesn't think they dwarf his mission. After all, Lovato has him to thank.
"Putting it in the hands of everyone and anyone is critical," Crystal said.
For more on this story, [click here](https://cheddar.com/videos/how-one-pharmaceutical-company-is-fighting-the-opioid-epidemic).
Sophie Bushwick, senior editor for Popular Science, discusses the Trump administration's recent announcement to scale back the size of two national monuments in Utah, which are home to over 400 research sites employing 2,000 scientists.
"The Devil Wears Prada" and "Entourage" star is working with Dell to prevent plastic from entering the ocean.
Kimbal Musk is on a mission to base the American restaurant and food system on clean farming and eating. He is transforming food the same way his brother, Elon, is transforming electric cars and space travel.
Can you remember the last time you had a good night's sleep? Many people go weeks without sleeping through the entire night. Marina Khidekel, Senior Deputy Editor at Women's Health, joins Cheddar to talk about its latest sleep study in partnership with Thrive Global and the American Sleep Association.
Boeing's Chief Executive has once again told the public his company will beat Elon Musk's SpaceX in its mission to Mars. Will Goodman, Managing Editor at Rockets are Cool, joins Cheddar to discuss the competition between the two aviation companies.
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
Woebot is an A.I. chat robot on Facebook that is increasing access to therapy. The new chatbot is a digital alternative to going to see a therapist, and is currently free.
Could a merger of SpaceX and Tesla be in Elon Musk's future?
An analyst at Morgan Stanley seems to think so, writing a note that lays out several reasons why, he thinks, a full partnership between the two companies could happen. Linda Lacina, Managing Editor at Entrepreneur joins Cheddar to discuss the news.
Kelly Noonan Gores takes viewers inside the connection between our bodies and minds with her new critically-acclaimed documentary “Heal.” She sits down with Alyssa Julya Smith at Cheddar’s WeWork studio in Los Angeles to discuss the spiritual journey people take to become healthy, and to rid the body of stressors that can cause illness.
Glassdoor Co-founder and CEO Robert Hohman tells Cheddar how the top employers made the cut.
